Roboearth – Lifestyle
Author:
ImmuCell Corporation
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
May 7, 2026
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
April 13, 2026
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
April 8, 2026
ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to Board
March 18, 2026